Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125799962 | 12579996 | 2 | F | 2010 | 20160718 | 20160721 | 20160815 | PER | US-ASTRAZENECA-2016SE12387 | ASTRAZENECA | 57.00 | YR | M | Y | 68.00000 | KG | 20160816 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125799962 | 12579996 | 1 | PS | TAGRISSO | OSIMERTINIB | 1 | Oral | 12240 | MG | 208065 | 80 | MG | TABLET | QD | |||||
| 125799962 | 12579996 | 2 | SS | TAGRISSO | OSIMERTINIB | 1 | Oral | 12240 | MG | 208065 | 80 | MG | TABLET | QD | |||||
| 125799962 | 12579996 | 3 | SS | PULMICORT FLEXHALER | BUDESONIDE | 1 | Respiratory (inhalation) | ONE SQUIRT AS NEEDED | 0 | INHALATION POWDER | |||||||||
| 125799962 | 12579996 | 4 | SS | PULMICORT FLEXHALER | BUDESONIDE | 1 | Respiratory (inhalation) | ONE SQUIRT AS NEEDED | 0 | INHALATION POWDER | |||||||||
| 125799962 | 12579996 | 5 | SS | PULMICORT FLEXHALER | BUDESONIDE | 1 | Respiratory (inhalation) | ONE SQUIRT AS NEEDED | 0 | INHALATION POWDER | |||||||||
| 125799962 | 12579996 | 6 | SS | PULMICORT FLEXHALER | BUDESONIDE | 1 | Respiratory (inhalation) | 0 | NEBULISER SUSPENSION | ||||||||||
| 125799962 | 12579996 | 7 | SS | PULMICORT FLEXHALER | BUDESONIDE | 1 | Respiratory (inhalation) | 0 | NEBULISER SUSPENSION | ||||||||||
| 125799962 | 12579996 | 8 | SS | PULMICORT FLEXHALER | BUDESONIDE | 1 | Respiratory (inhalation) | 0 | NEBULISER SUSPENSION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125799962 | 12579996 | 1 | Lung neoplasm malignant |
| 125799962 | 12579996 | 2 | Lung neoplasm malignant |
| 125799962 | 12579996 | 3 | Bronchitis |
| 125799962 | 12579996 | 4 | Prophylaxis |
| 125799962 | 12579996 | 5 | Chronic obstructive pulmonary disease |
| 125799962 | 12579996 | 6 | Bronchitis |
| 125799962 | 12579996 | 7 | Prophylaxis |
| 125799962 | 12579996 | 8 | Chronic obstructive pulmonary disease |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125799962 | 12579996 | Arthralgia | |
| 125799962 | 12579996 | Bronchitis | |
| 125799962 | 12579996 | Fatigue | |
| 125799962 | 12579996 | Hypotrichosis | |
| 125799962 | 12579996 | Insomnia | |
| 125799962 | 12579996 | Myalgia | |
| 125799962 | 12579996 | Off label use | |
| 125799962 | 12579996 | Tendonitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125799962 | 12579996 | 1 | 20160119 | 0 | ||
| 125799962 | 12579996 | 2 | 20160119 | 0 | ||
| 125799962 | 12579996 | 3 | 2010 | 0 | ||
| 125799962 | 12579996 | 4 | 2010 | 0 | ||
| 125799962 | 12579996 | 5 | 2010 | 0 | ||
| 125799962 | 12579996 | 6 | 2010 | 0 | ||
| 125799962 | 12579996 | 7 | 2010 | 0 | ||
| 125799962 | 12579996 | 8 | 2010 | 0 |